- Recommendation ID
- IPG579/1
- Question
Further research, preferably in the form of randomised controlled trials, should assess the effect of the procedure on local tumour control, patient survival, pain
control and quality of life.- Any explanatory notes
(if applicable) Current evidence on the safety and efficacy of irreversible electroporation for treating pancreatic cancer is inadequate in quantity and quality. Therefore, this procedure should only be used in the context of research.
Source guidance details
- Comes from guidance
- Irreversible electroporation for treating pancreatic cancer
- Number
- IPG579
- Date issued
- May 2017
Other details
| Is this a recommendation for the use of a technology only in the context of research? | No |
| Is it a recommendation that suggests collection of data or the establishment of a register? | No |
| Last Reviewed | 31/05/2017 |